.Friday, September 1, 2024 07:00 AM

In the biopharmaceutical industry, G1 Therapeutics, Inc. (NASDAQ:GTHX) is struggling financially with a ROIC of -57.38% and a WACC of 11.84%, indicating a lack of returns above its cost of capital. On the other hand, Atara Biotherapeutics, Inc. (NASDAQ:ATRA) shines with a ROIC of 280.02% and a WACC of 6.35%, showcasing efficient capital utilization. The analysis emphasizes the importance of evaluating companies based on metrics like ROIC/WACC ratio to gauge their financial health and investment potential. Other industry peers also present varied financial health, highlighting the diverse investment profiles within the sector.